期刊文献+

二甲双胍通过调节肠道菌群抗肿瘤机制的研究进展 被引量:3

Progress of anti-tumor mechanism of metformin through regulation of gut microbiota
原文传递
导出
摘要 近年来研究发现肠道微生态与肿瘤的发生、发展及治疗密切相关,文章就二甲双胍通过调节肠道菌群抗肿瘤机制的研究进展进行总结,并对研究过程中出现的问题进行综述和展望。 In recent years, the studies have found that the intestinal micro-ecology is closely related to the development and treatment of tumors. This article aims to summarize the advance of anti-tumor mechanism of metformin through regulation of gut microbiota, describe the problems and its prospect in the research process.
作者 王依朝 苏文 Wang Yizhao;Su Wen(the Second Clinical Medical College of Shanxi Medical University, Taiyuan 030001, China;Department of Immunology, Affiliated Cancer Hospital of Shanxi Medical University, Shanxi Provincial Cancer Institute, Taiyuan 030013, China)
出处 《肿瘤研究与临床》 CAS 2019年第6期429-432,共4页 Cancer Research and Clinic
关键词 二甲双胍 抗肿瘤 肿瘤免疫 肠道菌群 Metformin Antitumor Tumor immunology Gut microbiota
  • 相关文献

参考文献2

二级参考文献50

  • 1Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes [ J ]. Diabetola, 2015, 58 (3): 429-42.
  • 2Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report [ J ]. Diabetes Care, 2010, 33 ( 7 ) : 1674-1685.
  • 3Gandini S, Puntoni M, Heckman-Stoddard BM, et al. Mefformin and cancer risk and mortality: a systematic review and recta-analysis taking into account biases and confounders [ J ]. Cancer Prey Res ( Phila ), 2014, 7 ( 9 ) : 867-885.
  • 4Chlebowski RT, McTiernan A, Wactawski-Wende J, et al. Diabetes, metformin, and breast cancer in postmenopausal women [ J ]. J Clin Oncol, 2012, 30 ( 23 ) : 2844-2852.
  • 5Campagnoli C, Berrino F, Venturelli E, et al. Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancer [ J ]. Clin Breast Cancer, 2013, 13 (6) : 433-438.
  • 6Hadad S, Iwamoto T, Jordan L, et al. Evidence for biological effects of mefformin in operable breast cancer: a pre-operative, window-of- opportunity, randomized trial [ J ]. Breast Cancer Res Treat, 2011, 128 ( 3 ) : 783-794.
  • 7Niraula S, Dowling RJ, Etanis M, et al. Mefformin in early breast cancer: a prospective window of opportunity neoadjuvant study [ J ]. Breast Cancer Res Treat, 2012, 135 (3) : 821-830.
  • 8Ko EM, Walter P, Clark L, et al. The complex triad of obesity, diabetes and race in type I and I1 endometrial cancers: prevalence and prognostic significance [ J ]. Gynecol Oncol, 2014, 133 ( 1 ) : 28-32.
  • 9Zhang Y, Liu H, Yang S, et al. Overweight, obesity and endometrial cancer risk: results from a systematic review and meta-analysis [ J ]. Int J Biol Markers, 2014, 29 ( 1 ) : e21-29.
  • 10Nevadunsky NS, van Arsdale A, Strickler HD, et al. Metformin use and endometrial cancer survival [ J ]. Gynecol Oncol, 2014, 132 ( 1 ) : 236-240.

共引文献14

同被引文献37

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部